Marathon Asset Management (UK)’s Abiomed Inc ABMD Stock Holding History

Marathon Asset Management (UK)’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-201,856	Closed	-$65.7M	–	120
2021 Q3	$65.7M	Buy	201,856 +42,926	+27%	+$14.5M	0.8%	52
2021 Q2	$49.6M	Buy	158,930 +60,071	+61%	+$18.4M	0.6%	63
2021 Q1	$31.5M	Sell	98,859 -2,862	-3%	-$916K	0.44%	82
2020 Q4	$33M	Sell	101,721 -3,858	-4%	-$1.07M	0.46%	82
2020 Q3	$29.2M	Sell	105,579 -43,288	-29%	-$12.5M	0.46%	79
2020 Q2	$36M	Buy	148,867 +42,251	+40%	+$8.48M	0.55%	67
2020 Q1	$15.5M	Sell	106,616 -5,074	-5%	-$842K	0.28%	92
2019 Q4	$19.1M	Sell	111,690 -8,653	-7%	-$1.6M	0.25%	93
2019 Q3	$21.4M	Buy	+120,343	New	+$26M	0.28%	88

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Marathon Asset Management (UK)'s ABMD Position: Q4 2021 in Review

Marathon Asset Management (UK) sold out of Abiomed Inc (ABMD) in Q4 2021, closing a stake of 201,856 shares — an estimated $65.7M sold.

Marathon Asset Management (UK) first reported a position in ABMD in Q3 2019 and held it in 9 quarters. The position peaked at $65.7M in Q3 2021. 496 funds tracked by Wall St. Rank hold ABMD as of Q4 2021.

Marathon Asset Management (UK) reported no remaining Abiomed Inc position as of Q4 2021 after selling out during the quarter.
Marathon Asset Management (UK) sold 201,856 Abiomed Inc shares in Q4 2021, an estimated $65.7M.
Marathon Asset Management (UK) first reported a position in Abiomed Inc in Q3 2019 and held it in 9 quarters.
Marathon Asset Management (UK)'s Abiomed Inc position peaked at $65.7M in Q3 2021.
496 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2021.

Based on Marathon Asset Management (UK)'s 13F filing for Q4 2021, filed 28 Jan 2022.